The performance of the PENN-PET 240H scanner from UGM Medical Systems is tested and compared to the prototype PENN-PET scanner built at the University of Pennsylvania. The UGM PENN-PET scanner consists of six continuous position-sensitive NaI(Tl) detectors, which results in a 50 cm transverse field-of-view and a 12.8 cm axial field-of-view. The fine spatial sampling in the axial direction allows the data to be sorted into as many as 64 transverse planes, each 2 mm thick. A large axial acceptance angle, without interplane septa, results in a high-sensitivity and low-randoms fraction, with a low-scatter fraction due to the use of a narrow photopeak energy window. This work emphasizes those performance measurements that illustrate the special characteristics of a volume imaging scanner and how they change as the axial length is increased.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1109/42.232259 | DOI Listing |
J Nucl Med
August 2003
Department of Radiology, Hospital of the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA.
Unlabelled: A high-sensitivity, high-resolution brain PET scanner ("G-PET") has been developed. This scanner is similar in geometry to a previous brain scanner developed at the University of Pennsylvania, the HEAD Penn-PET, but the detector technology and electronics have been improved to achieve enhanced performance.
Methods: This scanner has a detector ring diameter of 42.
Clin Nucl Med
July 2003
Division of Nuclear Medicine, Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, 19104, USA.
Purpose: This study was designed to validate a simple scoring system for evaluating fluorodeoxyglucose (FDG) positron emission tomographic (PET) scans that can be used routinely in patients undergoing the clinical assessment of cognitive impairment.
Methods: The FDG-PET scans of 106 patients with cognitive impairment (65 with Alzheimer disease, 16 with frontal lobe dementia, and 25 atypical cases) were acquired using the PENN-PET scanner 40 minutes after the intravenous administration of 8 mCi FDG. Metabolic activity in various anatomic structures of the brain was scored using the following qualitative scale: 4 = normal; 3 = mildly decreased; 2 = moderately decreased; 1 = severely decreased; and 0 = no activity.
Eur J Nucl Med Mol Imaging
February 2003
University of Pennsylvania School of Veterinary Medicine, Section of Radiology, 3850 Spruce Street, Philadelphia, PA 19104, USA.
Tumor hypoxia is an important prognostic indicator for cancer therapy outcome. EF5 [2-(2-nitro-1[ H]-imidazol-1-yl)- N-(2,2,3,3,3-pentafluoropropyl)-acetamide] has been employed to measure tumor hypoxia in animals and humans using immunohistochemical methods. EF5 is a lipophilic molecule designed to have a very uniform biodistribution, a feature of obvious benefit for use in PET imaging.
View Article and Find Full Text PDFActa Oncol
December 2002
Department of Oncology, Turku University Hospital, Finland.
The aim of this study was to investigate FDG-PET (fluorodeoxyglucose positron emission tomography) imaging in the management of prostate cancer. Twenty-two patients were studied during different disease phases of prostate cancer, for staging or restaging to clarify specific clinical questions. FDG-PET was performed encompassing the thorax, abdomen and pelvis using the Penn PET 300H scanner.
View Article and Find Full Text PDFJ Nucl Med
December 2001
Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Unlabelled: A whole-body PET scanner, without interplane septa, has been designed to achieve high performance in clinical applications. The C-PET scanner, an advancement of the PENN PET scanners, is unique in the use of 6 curved NaI(Tl) detectors (2.54 cm thick).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!